499 related articles for article (PubMed ID: 17205073)
1. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
Gold R; Stangel M; Dalakas MC
Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
[TBL] [Abstract][Full Text] [Related]
2. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara I; Hietaharju A
Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
4. Guidelines on the use of intravenous immune globulin for neurologic conditions.
Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
[TBL] [Abstract][Full Text] [Related]
5. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
Lewańska M; Selmaj K
Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417
[TBL] [Abstract][Full Text] [Related]
7. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
Donofrio PD; Berger A; Brannagan TH; Bromberg MB; Howard JF; Latov N; Quick A; Tandan R
Muscle Nerve; 2009 Nov; 40(5):890-900. PubMed ID: 19768755
[TBL] [Abstract][Full Text] [Related]
8. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
Molnár MJ
Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
[TBL] [Abstract][Full Text] [Related]
9. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.
Darabi K; Abdel-Wahab O; Dzik WH
Transfusion; 2006 May; 46(5):741-53. PubMed ID: 16686841
[TBL] [Abstract][Full Text] [Related]
10. [Use of high dose intravenous immunoglobulin in neurologic disease].
Korsak J; Zaleska B; Orłowska E; Kotowicz J
Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.
Lünemann JD; Nimmerjahn F; Dalakas MC
Nat Rev Neurol; 2015 Feb; 11(2):80-9. PubMed ID: 25561275
[TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
Rütter A; Luger TA
J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
[TBL] [Abstract][Full Text] [Related]
13. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
Lehmann HC; Hartung HP
J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
Stangel M; Hartung HP; Marx P; Gold R
J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
[TBL] [Abstract][Full Text] [Related]
15. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
Sørensen PS
Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
[TBL] [Abstract][Full Text] [Related]
16. [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].
Gold R; Hartung HP; Toyka KV
Fortschr Neurol Psychiatr; 1995 Jan; 63(1):17-29. PubMed ID: 7883268
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V;
Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178
[TBL] [Abstract][Full Text] [Related]
18. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
